American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Representation of older adults in FDA and EMA registrational trials for acute myeloid leukemia (AML)
    Meeting Abstract

    Pugh, K.; Juthani, R.; Torka, P.; Neuendorff, N.
    Blood (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma - International, multi-center real-world experience
    Meeting Abstract

    Luttwak, E.; Kambhampati, S.; Drill, E.; Ganesan, N.; Hofstetter, L.; Gurion, R.; Aumann, S.; Haran, A.; Geva, M.; Panossian, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study
    Meeting Abstract

    Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Reduction in platelet counts may predict the development of immune effector cell associated neurotoxicity syndrome in patients receiving CD19 CAR-T cell therapy for relapsed/refractory large B cell lymphoma
    Meeting Abstract

    Khatib, H.; Parizat, A.; Halloun, J.; Shouval, R.; Shibli, N.; Alalouf, O.; Zuckerman, T.; Vahaba, N.; Halamish, I.; Sapir, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Thedevelopment of diagnostic criteria and utilization of excisional lymph node biopsies shorten time to diagnosis for idiopathic multicentric Castleman Disease
    Meeting Abstract

    Bustamante, M. S.; Lavery, C. L. M.; Bagg, A.; Lechowicz, M. J.; Alapat, D.; Chadburn, A.; Lim, M. S.; Srkalovic, G.; van Rhee, F.; Brandstadter, J. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Cytarabine resistance leads to a specific mutator phenotype in leukemic cells
    Meeting Abstract

    Cao, D. C.; Yin, M. M.; Baslan, T.; Bertoli, R.; Zhang, Z. H.; Zhu, Y. L.; Meltzer, P. S.; Aplan, P. D.
    Blood (2024)

    Fulltext@MSK | Save
  • The role of the bone marrow immune niche in preventing relapse in adult B-ALL following reduced intensity conditioning allogeneic HSCT
    Meeting Abstract

    Allen, H. E.; McIntyre, A.; Gutierrez-Abril, J.; Kirkwood, A. A.; Leongamornlert, D.; Amerikanou, R.; Cutler, E. A.; Dey, A.; Burt, R.; Chakraverty, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Age-related prognoses of genetic subtypes in B-cell acute lymphoblastic leukemia/lymphoma (B-ALL): Insights from a decade of national data
    Meeting Abstract

    Zhou, T.; Short, N. J.; Jain, N.; Patel, K. P.; Jabbour, E.; Kantarjian, H. M.; Medeiros, L. J.; Iorgulescu, B.
    Blood (2024)

    Fulltext@MSK | Save
  • Leukemiaphysician's perspective on transplant in patients with TP53 mutated acute myeloid leukemia
    Meeting Abstract

    Vanegas, Y. A. M.; El Khatib, S. Y. M.; Hisrich, B.; Coltoff, A.; Shallis, R. M.; Patel, A. A.; Bewersdorf, J. P.; Oh, T. S.; Abaza, Y.; Foucar, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Mosunetuzumab monotherapy demonstrates encouraging activity and a manageable safety profile in patients with heavily pre-treated relapsed or refractory mantle cell lymphoma
    Meeting Abstract

    Budde, E. L.; Matasar, M.; Sehn, L. H.; Assouline, S. E.; Kuruvilla, J.; Flinn, I. W.; Yoon, S. S.; Bosch, F.; Greenwald, D.; Gutierrez, N. C.; more...
    Blood (2024)

    Fulltext@MSK | Save